Astellas has ended work on a cell therapy that it was exploring for CD20-positive B cell lymphomas, the Japan-based pharma ...

Transcarent acquires Accolade for $621M in cash deal led by CEO Glen Tullman, combining health navigation platforms.

Scribe Therapeutics, a biotech co-founded by CRISPR pioneer Jennifer Doudna, is reducing its workforce by about 20%.

National Resilience is laying off 120 staffers from its gene therapy facility in North Carolina, only a month after the San ...

Sana stock soars on diabetes therapy data, UniQure's offering, BioInvent's lymphoma success, Alpha's Zunveyl deal, Neumirna funding, and Cassava's layoffs.

A new startup aiming to tackle rare diseases de-stealthed Wednesday morning with a CEO experienced in the space. Alesta ...

Roche's Chugai partners with Araris Biotech on multi-payload ADCs, as Swiss biotech advances tech allowing multiple cytotoxic ...

Aspect Biosystems raises $115M Series B for bioprinted tissue therapeutics targeting diabetes and metabolic disorders, led by ...

Ahead of the busiest week for biopharma dealmaking at the annual JP Morgan Healthcare Conference, a new startup launched, ...

Vir Biotechnology reports early data on T cell engagers VIR-5818 and VIR-5500, licensed from Sanofi, showing tumor shrinkage ...

A private startup looking to bring an old schizophrenia drug class to the US has released new Phase 2 data and aims to start ...

Jasper Therapeutics continued building out the data for a drug designed to treat irritable skin conditions, though the latest ...